ANIP logo

ANI Pharmaceuticals (ANIP) Free cash flow

annual FCF:

$47.06M-$53.38M(-53.15%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual free cash flow is $47.06 million, with the most recent change of -$53.38 million (-53.15%) on December 31, 2024.
  • During the last 3 years, ANIP annual FCF has risen by +$67.38 million (+331.66%).
  • ANIP annual FCF is now -53.15% below its all-time high of $100.45 million, reached on December 31, 2023.

Performance

ANIP Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

quarterly FCF:

$15.14M+$1.76M(+13.19%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly free cash flow is $15.14 million, with the most recent change of +$1.76 million (+13.19%) on March 31, 2025.
  • Over the past year, ANIP quarterly FCF has increased by +$1.46 million (+10.64%).
  • ANIP quarterly FCF is now -62.10% below its all-time high of $39.96 million, reached on December 31, 2023.

Performance

ANIP quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM FCF:

$48.52M+$1.46M(+3.10%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM free cash flow is $48.52 million, with the most recent change of +$1.46 million (+3.10%) on March 31, 2025.
  • Over the past year, ANIP TTM FCF has dropped by -$46.54 million (-48.96%).
  • ANIP TTM FCF is now -51.70% below its all-time high of $100.45 million, reached on December 31, 2023.

Performance

ANIP TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ANIP Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-53.1%+10.6%-49.0%
3 y3 years+331.7%+171.7%+179.1%
5 y5 years+160.3%+127.1%+252.8%

ANIP Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-53.1%+198.8%-62.1%+171.7%-51.7%+179.1%
5 y5-year-53.1%+188.7%-62.1%+127.1%-51.7%+179.1%
alltimeall time-53.1%+138.7%-62.1%+120.3%-51.7%+133.4%

ANIP Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$15.14M(+13.2%)
$48.52M(+3.1%)
Dec 2024
$47.06M(-53.1%)
$13.38M(+90.3%)
$47.06M(-36.1%)
Sep 2024
-
$7.03M(-45.8%)
$73.64M(-21.8%)
Jun 2024
-
$12.96M(-5.3%)
$94.23M(-0.9%)
Mar 2024
-
$13.69M(-65.7%)
$95.06M(-5.4%)
Dec 2023
$100.45M(-310.8%)
$39.96M(+44.7%)
$100.45M(+89.7%)
Sep 2023
-
$27.62M(+100.1%)
$52.95M(+176.6%)
Jun 2023
-
$13.80M(-27.6%)
$19.14M(-356.3%)
Mar 2023
-
$19.07M(-352.9%)
-$7.47M(-84.3%)
Dec 2022
-$47.66M(+134.6%)
-$7.54M(+21.8%)
-$47.66M(-9.5%)
Sep 2022
-
-$6.19M(-51.7%)
-$52.67M(+0.4%)
Jun 2022
-
-$12.80M(-39.4%)
-$52.46M(-14.5%)
Mar 2022
-
-$21.12M(+68.2%)
-$61.37M(+202.1%)
Dec 2021
-$20.32M(-61.7%)
-$12.55M(+109.7%)
-$20.32M(+30.3%)
Sep 2021
-
-$5.99M(-72.4%)
-$15.59M(-8.4%)
Jun 2021
-
-$21.71M(-208.9%)
-$17.03M(-175.0%)
Mar 2021
-
$19.93M(-354.6%)
$22.71M(-142.8%)
Dec 2020
-$53.05M(-393.4%)
-$7.83M(+5.5%)
-$53.05M(+26.9%)
Sep 2020
-
-$7.42M(-141.2%)
-$41.80M(+188.0%)
Jun 2020
-
$18.03M(-132.3%)
-$14.51M(-54.3%)
Mar 2020
-
-$55.84M(-1728.3%)
-$31.76M(-275.6%)
Dec 2019
$18.08M(-67.8%)
$3.43M(-82.7%)
$18.08M(-55.8%)
Sep 2019
-
$19.86M(+2426.8%)
$40.88M(+46.2%)
Jun 2019
-
$786.00K(-113.1%)
$27.96M(-5.3%)
Mar 2019
-
-$5.99M(-122.9%)
$29.52M(-47.4%)
Dec 2018
$56.16M(-181.9%)
$26.23M(+277.5%)
$56.16M(-1384.3%)
Sep 2018
-
$6.95M(+197.1%)
-$4.37M(-233.2%)
Jun 2018
-
$2.34M(-88.7%)
$3.28M(-342.0%)
Mar 2018
-
$20.65M(-160.2%)
-$1.36M(-98.0%)
Dec 2017
-$68.57M(-43.6%)
-$34.31M(-334.9%)
-$68.57M(+190.9%)
Sep 2017
-
$14.60M(-734.1%)
-$23.57M(-38.3%)
Jun 2017
-
-$2.30M(-95.1%)
-$38.18M(-59.2%)
Mar 2017
-
-$46.56M(-535.5%)
-$93.57M(-23.0%)
Dec 2016
-$121.59M(+688.6%)
$10.69M(<-9900.0%)
-$121.59M(-5.5%)
Sep 2016
-
-$5000.00(-100.0%)
-$128.68M(-11.4%)
Jun 2016
-
-$57.69M(-22.6%)
-$145.21M(+67.9%)
Mar 2016
-
-$74.58M(-2173.5%)
-$86.51M(+461.1%)
Dec 2015
-$15.42M(+12.4%)
$3.60M(-121.8%)
-$15.42M(+79.0%)
Sep 2015
-
-$16.53M(-1740.1%)
-$8.61M(-17.6%)
Jun 2015
-
$1.01M(-128.9%)
-$10.45M(+7.1%)
Mar 2015
-
-$3.49M(-133.6%)
-$9.76M(-28.9%)
Dec 2014
-$13.72M(+141.8%)
$10.40M(-156.6%)
-$13.72M(-49.2%)
Sep 2014
-
-$18.37M(-1179.9%)
-$27.02M(+162.0%)
Jun 2014
-
$1.70M(-122.8%)
-$10.31M(+14.8%)
Mar 2014
-
-$7.46M(+157.6%)
-$8.99M(+58.3%)
Dec 2013
-$5.67M(-78.1%)
-$2.89M(+73.8%)
-$5.67M(-5.9%)
Sep 2013
-
-$1.67M(-155.0%)
-$6.03M(-50.6%)
Jun 2013
-
$3.03M(-173.1%)
-$12.21M(-45.2%)
Mar 2013
-
-$4.15M(+27.7%)
-$22.30M(-13.9%)
Dec 2012
-$25.89M
-$3.25M(-58.6%)
-$25.89M(-23.0%)
Sep 2012
-
-$7.85M(+11.2%)
-$33.65M(-12.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$7.06M(-8.9%)
-$38.48M(-15.7%)
Mar 2012
-
-$7.74M(-29.6%)
-$45.64M(-6.1%)
Dec 2011
-$48.59M(+21.0%)
-$11.00M(-13.3%)
-$48.59M(-6.2%)
Sep 2011
-
-$12.69M(-10.7%)
-$51.83M(+3.7%)
Jun 2011
-
-$14.21M(+32.9%)
-$50.00M(+11.9%)
Mar 2011
-
-$10.69M(-24.9%)
-$44.69M(+11.3%)
Dec 2010
-$40.16M(+116.0%)
-$14.24M(+31.1%)
-$40.16M(+25.2%)
Sep 2010
-
-$10.86M(+22.0%)
-$32.07M(+28.6%)
Jun 2010
-
-$8.90M(+44.2%)
-$24.94M(+23.8%)
Mar 2010
-
-$6.17M(+0.3%)
-$20.15M(+8.4%)
Dec 2009
-$18.60M(+14.9%)
-$6.15M(+64.9%)
-$18.60M(+21.5%)
Sep 2009
-
-$3.73M(-9.2%)
-$15.30M(-13.2%)
Jun 2009
-
-$4.11M(-11.0%)
-$17.63M(-3.8%)
Mar 2009
-
-$4.61M(+61.5%)
-$18.32M(+13.2%)
Dec 2008
-$16.19M(-2377.9%)
-$2.86M(-52.8%)
-$16.19M(+34.3%)
Sep 2008
-
-$6.06M(+26.2%)
-$12.06M(+49.4%)
Jun 2008
-
-$4.80M(+93.9%)
-$8.07M(+51.7%)
Mar 2008
-
-$2.47M(-294.1%)
-$5.32M(-848.7%)
Dec 2007
$710.60K(-114.1%)
$1.27M(-161.5%)
$710.50K(+15.5%)
Sep 2007
-
-$2.07M(+1.3%)
$615.40K(-52.9%)
Jun 2007
-
-$2.05M(-157.6%)
$1.31M(+61.3%)
Mar 2007
-
$3.56M(+201.3%)
$809.70K(-116.1%)
Dec 2006
-$5.04M(-39.8%)
$1.18M(-185.4%)
-$5.04M(-32.1%)
Sep 2006
-
-$1.38M(-45.7%)
-$7.41M(-5.0%)
Jun 2006
-
-$2.54M(+11.0%)
-$7.80M(-2.2%)
Mar 2006
-
-$2.29M(+91.2%)
-$7.98M(-4.6%)
Dec 2005
-$8.36M(-20.7%)
-$1.20M(-32.4%)
-$8.37M(-21.8%)
Sep 2005
-
-$1.77M(-34.7%)
-$10.70M(-8.3%)
Jun 2005
-
-$2.72M(+1.5%)
-$11.67M(+2.7%)
Mar 2005
-
-$2.68M(-24.3%)
-$11.36M(+7.7%)
Dec 2004
-$10.55M(+90.7%)
-$3.53M(+29.0%)
-$10.55M(+25.6%)
Sep 2004
-
-$2.74M(+13.7%)
-$8.40M(+15.7%)
Jun 2004
-
-$2.41M(+29.3%)
-$7.26M(+22.5%)
Mar 2004
-
-$1.86M(+34.4%)
-$5.92M(+7.1%)
Dec 2003
-$5.53M(+38.2%)
-$1.39M(-13.3%)
-$5.53M(+23.9%)
Sep 2003
-
-$1.60M(+48.8%)
-$4.47M(+17.6%)
Jun 2003
-
-$1.07M(-27.0%)
-$3.80M(-8.2%)
Mar 2003
-
-$1.47M(+358.6%)
-$4.14M(+3.3%)
Dec 2002
-$4.00M(+109.4%)
-$321.00K(-65.5%)
-$4.00M(-21.0%)
Sep 2002
-
-$929.30K(-34.2%)
-$5.07M(+60.4%)
Jun 2002
-
-$1.41M(+5.6%)
-$3.16M(+28.3%)
Mar 2002
-
-$1.34M(-3.4%)
-$2.46M(+28.8%)
Dec 2001
-$1.91M(-40.2%)
-$1.38M(-241.5%)
-$1.91M(+75.1%)
Sep 2001
-
$978.50K(-236.6%)
-$1.09M(-60.6%)
Jun 2001
-
-$716.50K(-9.1%)
-$2.77M(-21.2%)
Mar 2001
-
-$787.80K(+39.4%)
-$3.51M(+9.9%)
Dec 2000
-$3.19M(+78.2%)
-$565.20K(-18.8%)
-$3.19M(+21.5%)
Sep 2000
-
-$696.20K(-52.3%)
-$2.63M(+36.0%)
Jun 2000
-
-$1.46M(+208.8%)
-$1.93M(+308.8%)
Mar 2000
-
-$472.50K
-$472.50K
Dec 1999
-$1.79M(-43.4%)
-
-
Dec 1998
-$3.17M
-
-

FAQ

  • What is ANI Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual FCF year-on-year change?
  • What is ANI Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly FCF year-on-year change?
  • What is ANI Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM FCF year-on-year change?

What is ANI Pharmaceuticals annual free cash flow?

The current annual FCF of ANIP is $47.06M

What is the all time high annual FCF for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual free cash flow is $100.45M

What is ANI Pharmaceuticals annual FCF year-on-year change?

Over the past year, ANIP annual free cash flow has changed by -$53.38M (-53.15%)

What is ANI Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of ANIP is $15.14M

What is the all time high quarterly FCF for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly free cash flow is $39.96M

What is ANI Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, ANIP quarterly free cash flow has changed by +$1.46M (+10.64%)

What is ANI Pharmaceuticals TTM free cash flow?

The current TTM FCF of ANIP is $48.52M

What is the all time high TTM FCF for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM free cash flow is $100.45M

What is ANI Pharmaceuticals TTM FCF year-on-year change?

Over the past year, ANIP TTM free cash flow has changed by -$46.54M (-48.96%)
On this page